A combined oncogenic pathway signature of braf, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction

Sun Tian, Iris Simon, Victor Moreno, Paul Roepman, Josep Tabernero, Mireille Snel, Laura Van't Veer, Ramon Salazar, Rene Bernards, Gabriel Capella

Research output: Contribution to journalArticleResearchpeer-review

92 Citations (Scopus)

Fingerprint Dive into the research topics of 'A combined oncogenic pathway signature of braf, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction'. Together they form a unique fingerprint.

Medicine & Life Sciences